Zandu Pharmaceutical Works, the Rs 76.35-crore ayurvedic major, has chalked out a Rs 22-crore expansion plan and is scouting for partners to distribute its products overseas.
D M Parikh, vice-president of the Zandu Pharmaceuticals, said that the Rs 22-crore corpus would be utilised mainly for expanding the capacity of the formulations plant which is based at Silvassa in the state of Gujarat.
The plant, which will produce powders, liquids and ointments, will start commercial production by October this year.
Also Read
The expansion will be funded by a Rs 13.5-crore loan from Industrial Credit and Investment Corporation of India (ICICI), with the rest to be sourced through internal accruals.
We are also setting up a small plant in Dindigal, Hyderabad, for products like balms and ointments, he said.
The company already has plants in Mumbai and Talasari in Maharashtra, Vapi in Gujarat, Unnao in UP, Piparia in Dadra and Nagar Haveli and Medak in Andhra Pradesh.
It has lined up the three products this year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app